Immunoassay for the purpose of solving current issues associated with standardization of allergen preparations

The present article describes principal problematic issues that refer to the standardization of allergen preparations. It is shown that at present domestic allergen preparations are being standardized by protein content in allergenic material, however, the mentioned characteristic does not reflect true allergic activity of a drug. There is a need in harmonization of domestic standardization technology for allergen preparations with the approaches of EMA (European Medicines Agency) and FDA (Food and Drug Administration), regulating their standardization in allergenic activity units, as well as the use of modern immunoassay methods for quantitative evaluation such as radioallergosorbent test, chemiluminescence analysis, immunoallergological test, enzyme-linked immunosorbent assay with inhibition phase etc.

препараты аллергенов, иммуноанализ, методы оценки активности препаратов аллергенов, стандартизация, аллергенная активность, единицы аллергенной активности, allergen preparations, immunoassay, methods for assessing the activity of allergen preparations, standardization, allergenic activity, allergenic activity units

1. Yalow R.S., Betson S.A. Assay of plasma Insulin in human subjects by immunological methods. Nature 1959; 184: 1648-9.

2. Хутуева С.Х., Федосеева В.Н. Аллергенспецифическая иммунотерапия бронхиальной астмы. М.: Экон; 2000.

3. Lowestein H., Wihl J., Bache B., Bowadt H. Rationale for shecific immunotherapy of grass pollen allergy with extract of rye pollen. Allergy 1984; 39 (5): 421-32.

4. Breiteneder H., Ferreira F., Hoffmann-Sommergruber K., Ebner C., Breitenbach M., Rumpold H., et al. Four recombinant isoforms of Cor a I., the major allergen of hazel pollen, show different IgE-binding properties. Eur J Biochem 1993; 212: 355-62.

5. Павлов А.Е., Сейлиева Н.А., Мухортых О.Ю., Стефанов В.Е. Получение и оценка свойств рекомбинантного аналога мажорного аллергена пыльцы березы Bet v 1. Российский аллергологический журнал 2012; 3: 7-13.

6. European Pharmacopoeia 7.0 01/2010:1063. Allergen product.

7. Yman L., Ponterius G., Brand R. Allergen assay and extract ponency estimation. Allergy Immunology 1979; 49: 55-62.

8. Colloff M., Merrett T., Merrett J., McSharry C., Boyd G. Feather mites are potentially an important source of allergens for pigeon and budgerigar keepers. Clin Exp Allergy 1997; 27(1): 60-7.

9. Tauer-Reich I., Fruhmann G., Czuppon A., Baur X. Allergens causing bird fancier’s asthma. Allergy 1994; 49(6): 448-53.

10. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76(9): 4350-4.

11. Медуницын Н.В. Вакцинология. М.: Триада-Х; 2010.

12. Радунская С.Ф., Лавренчик Е.И., Невская Л.В., Мосягин В.Д., Иванов В.Б. Проблемы оценки подлинности и специфической активности препаратов аллергенов. Биопрепараты 2013; 2 (46): 14-7.

13. Bousquet J., Lockey R., Malling H.J., Alvarez-Cuesta E., Canonica G.W., Chapman M.D., et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Ann Allergy Asthma Immunol 1998; 81: 401-5.

14. Chapman M.D., Ferreira F., Villalba M., Cromwell O. The European Union CREATE Project: A model for international standardization of allergy diagnostics and vaccines. J Allergy Clin Immunol. 2008; 122 (5): 882-9.

15. Filep S., Tsay A., Valies L., Gadermaier G., Ferreira F., Matsui E., et al. A multiallergen standart for calibration of immunoassay: CREATE principles applied to eight purified allergens. Allergy 2012; 67(2): 235-41.

16. Солдатов А.А., Медуницын Н.В., Авдеева Ж.И., Бондарев В.П., Миронов А.Н. Препараты лечебных аллергенов: проблемы и пути повышения качества, безопасности и эффективности. Ведомости НЦЭСМП 2013; 4: 31-7.

17. Фрадкин В.А. Диагностические и лечебные аллергены. М.: Медицина; 1990.